Twenty-five strains of enterotoxigenic (tox+) Escherichia coli isolated in India, Bangladesh, and the U.S.A. were shown to produce vascular permeability factor (PF) activity as well as diarrheagenic activity. Sixteen strains of non-enterotoxigenic E. coli were found to be PF negative. The PF response elicited by tox+ E. coli isolated in the U.S.A. from cases of infantile diarrhea was qualitatively different and more difficult to demonstrate. However, this problem was surmounted by assaying 25-fold concentrates of the crude enterotoxin of these strains. PF activity of various strains of tox+ E. coli was neutralized by anti-PF antiserum prepared against the enterotoxin of strain H-10407. This anti-PF antiserum also neutralized PF activity of Vibrio cholerae enterotoxin (choleragen). Antiserum containing antibody specific for purified choleragen neutralized E. coli PF activity. These and other results indicate that the PF activity of E. coli is a function of the diarrheagenic enterotoxin as is known to be the case with choleragen. We conclude that the PF assay can be employed for the identification of tox+ E. coli and for the detection of antitoxic antibody.
Since the original observations associating enterotoxigenic (tox+) Escherichia coli with human cases of diarrhea (4, 10, 17) , there has been abundant speculation concerning the incidence of this form of "toxigenic" diarrhea. Pursuit of this question has been hampered by the lack of a simple assay system for E. coli enterotoxin (ECT). The current method involves gastrointestinal challenge of animals with preparations of tox+ E. coli (7, 11, 15) . This technique is time consuming and allows considerable latitude of error. To complicate the situation, a recent study from Chicago has shown that strains of E. coli isolated from infantile diarrhea were often negative in the adult rabbit but proved to be positive in the infant rabbit model system (11) . The infant rabbit test is even more tedious than the adult rabbit model, and it can only be employed for small-scale investigations.
We have recently found that culture filtrates of tox+ E. coli isolated from man contain a factor that produces erythema, induration, and increased capillary permeability when injected into the skin of rabbits (manuscript submitted 731 for publication). The response to the ECT permeability factor (PF) activity was seen to be similar, but not identical, to that observed with Vibrio cholerae enterotoxin (choleragen) (2) . In this report we describe our observations concerning the usefulness of the PF assay in identifying the tox+ strains of E. coli. We have employed this method to assay strains isolated from both adult and infantile cases of diarrhea. In addition, the PF assay can be used to measure serum antitoxin titers. Application of the PF test in field studies should prove valuable in establishing the epidemiology of "toxigenic" diarrhea in man.
MATERIALS AND METHODS
Organisms. Twenty-five enterotoxigenic (tox+) and 16 non-enterotoxigenic (tox-) strains of E. coli were employed in this investigation. Of these, 18 tox+ and 15 tox -strains were isolated during studies on the association of E. coli with "acute undifferentiated diarrhea" in India (10) and Bangladesh (5, 6) . Three tox+ strains (474 B-5, 474 B-8, and 474 B-1) were obtained from cases of infantile diarrhea in Chicago (11) . Three tox+ strains (Ar-9, Ar-11A, and Ar-17C) were isolated during a recent epidemic of infantile EVANS, EVANS, AND GORBACH gastroenteritis in a hospital nursery in Arizona (8) . E. coli P-263 is a strain representative of those associated with colibacillosis in swine (12, 13) , and was kindly provided by H. W. Smith. Stock cultures were maintained on slants composed of 2.0% peptone (Difco), 0.5% NaCl, and 2.0% agar.
Enterotoxin preparation. The culture medium employed for demonstrating PF activity was prepared in the following manner: 20 g of Casamino Acids (Difco), 6.0 g of yeast extract (Difco), 2.5 g of NaCl, 8.71 g of K2HPO4 (0.05 M), and 1.0 ml of trace salts were added to distilled water in that order, adjusted to pH 8.5 with 0.1 N NaOH, and brought to a final volume of 1 liter. The trace salts mixture consisted of 5.0% MgSO4, 0.5% MnCl2, and 0.5% FeCl3 dissolved in 0.001 N H2SO4. Shake cultures (80 ml per 500-ml Erlenmeyer flask) were loop inoculated from stock slants and agitated on a rotary incubator shaker at 135 to 140 rpm for 18 h at 37 C. Cells were removed from the spent culture fluid by centrifugation at 12,000 x g for 45 min followed by membrane (0.45 im, Millipore Corp.) filtration.
Fifty-fold concentrates of enterotoxin were prepared as follows. Enterotoxin was precipitated from the culture fluid by slowly adding solid ammonium sulfate (AMS) to 90% saturation at 4 C with stirring, followed by 20 min without stirring. After centrifugation at 12,000 x g for 45 min at 4 C, the pellet was dissolved in 0.02 M tris(hydroxymethyl)aminomethane(Tris)-chloride buffer, pH 8 dard diluent, which also served as the negative control, consisted of sterile phosphate-buffered saline (PBS), pH 7.2, plus 0.02% bovine serum albumin (BSA). The standard positive control consisted of a 1:2 dilution, in PBS plus BSA, of sterile culture supernatant fluid of E. coli strain H-10407. All specimens were coded and tested in a "blind" manner. After inoculation, the animals were caged individually to avoid scratching. Eighteen hours later the animals were administered intravenously a solution (2.0% in 0.15 M NaCl) of Evans blue dye (Matheson Coleman and Bell) at a dose of 40 mg/kg of body weight. Two hours were allowed for permeation of the dye after which the induration and blueing of the lesions were recorded. The diameters of the zones were measured to the nearest millimeter in two different directions. The score was derived by squaring the average of the two values.
Preparation of antitoxins. The antigen preparation employed for the production of anti-E. coli enterotoxin was prepared by the following method. A 60-fold concentrate of the enterotoxin of E. coli strain H-10407 was first prepared by the AMS precipitation method described above. The enterotoxin was further purified and concentrated by precipitation with protamine sulfate (PRS), extraction of the precipitate with NaCl, and reprecipitation with AMS (manuscript submitted for publication). The final product, concentrated 600-fold with respect to the original culture fluid, is referred to as PRS-ECT.
Adult albino rabbits received seven sequential doses of approximately 65 ,ug of PRS-ECT at 4-day intervals. For the first inguinal injection, the antigen was emulsified in incomplete Freund adjuvant. The remaining doses, diluted in physiological saline, were injected intramuscularly at multiple sites. Fourteen days after the last injection, the rabbits were bled and sera were collected and pooled, distributed in 2.0-ml samples, and stored at -45 C. Control serum was a pool derived from the same rabbits prior to immunization.
Anticholeragen antiserum was prepared in rabbits by the same method. Purified choleragen (3 jig) was injected at multiple sites on three occasions at 4-day intervals; the animals were bled 10 days after the final injection. The anticholeragen serum used here was pooled serum from three animals. Neutralization of ECT PF activity of various strains of E. coli by anti-H-10407 ECT antiserum. Rabbit serum containing anti-H-10407 ECT antibody was obtained as described above. ECT of the various strains of E. coli tested, except that of P-263, consisted of culture supernatant fluid obtained under standard growth conditions. Strain P-263 ECT was a x50 concentrate prepared as described above. PF production by tox+ strains of E. coli isolated from cases of infantile diarrhea in Chicago (11) and Arizona (8) was also investigated ( Table 2 ). The results with this group of strains were qualitatively different from those of the India-Bangladesh group. The PF lesions produced by the Chicago-Arizona group were less indurated and the blueing was of lighter intensity. Large clear zones surrounded by blueing were not unusual. Some, but not all, of these strains failed to produce detectable lesions in individual rabbits even when x 25 ECT preparations were tested. Such failures were considered false-negative reactions since the injection sites which did react were unquestionably positive. Also, similar "ECT" preparations from tox-E. coli never produced detectable PF lesions even when tested at x 25 concentration.
Neutralization of PF activity of various strains of E. coli by anti-H-10407 ECT anti- serum. Table 3 shows that the PF activity of various strains of tox+ E. coli was completely neutralized by a 1:50 dilution of antiserum prepared against H-10407 ECT. The PF activity of a tox+ strain isolated from swine (P-263) was also completely neutralized by antiserum prepared against a strain isolated from a human (H-10407). Neutralization of choleragen PF activity by anti-H-10407 ECT antiserum. A dose of choleragen producing a PF lesion of 84 + 9 mm2 (blueing) was completely neutralized by a 1: 25 dilution of anti-ECT antiserum (Fig. 1) . The control serum did not neutralize choleragen PF activity. The PF assay showed a typical antibody titration curve with 50% neutralization of the choleragen PF activity with between 1:50 and 1: 100 antiserum.
Neutralization of ECT by anticholeragen antiserum. The x600 concentrated preparation of E. coli strain H-10407 ECT (PRS-ECT) was employed to test for neutralization of ECT PF activity by anticholeragen antibody. The antiserum, prepared against pure choleragen, neutralized a dose of ECT producing a PF lesion of 58 + 5 mm2 (blueing) at a dilution of 1: 100, with half-maximum neutralization at a dilution of 1: 500 (Fig. 2) . The control serum did not neutralize ECT PF activity. 
DISCUSSION
The association of diarrheagenic and vascular permeability activites has been well established in the case of cholera toxin (3, 9, 14) . Indeed, this relationship has established the PF assay as a valuable tool for studying both toxin production and serum antitoxin titers (3) . Several lines of evidence suggest that PF activity of E. coli enterotoxin is also associated with the diarrheagenic component. In the first instance, PF has a dose response curve and sensitivity similar to the heat-labile component of ECT which causes fluid accumulation in the rabbit ileal loop (manuscript submitted for publication). Antiserum raised against ECT of one strain of tox+ E. coli neutralizes the PF activity of the homologous strain as well as that of tox+ strains of on December 22, 2017 by guest http://iai.asm.org/ Downloaded from PF ASSAY FOR ENTEROTOXIGENIC E. COLI different serotypes; neutralization is observed with both the PF activity (blueing and induration) and the diarrheagenic activity (7) . Rather convincing evidence is that antiserum raised against purified cholera toxin (choleragen) neutralizes both the PF and loop activities of ECT. These several observations strongly indicate that the factor responsible for the PF activity of ECT is closely related to and perhaps identical with that which elicits diarrheagenic activity.
Culture supernatant preparations of enterotoxigenic strains isolated from patients with acute diarrhea in India and Bangladesh gave unequivocal PF reactions in all cases. On the other hand, 16 nontoxigenic strains were uniformly negative in this assay. Such perfect congruity was, however, not observed with tox+ strains isolated from infantile diarrhea cases in Chicago and Arizona since there was an incidence of false-negative reactions with some of these strains in individual rabbits. Also, the PF-positive strains from this group produced PF reactions qualitatively different from those observed with the strains from the Indian subcontinent: there was minimal induration, and the zone of blueing was lighter and less intense. A typical reaction produced by the strains isolated in the United States was a clear zone in the center surrounded by a light blue ring. However, there was no doubt that positive reactions, even in this somewhat unusual presentation, could be easily identified. Furthermore, non-enterotoxigenic strains failed to produce any form of reaction, even when concentrated 25-fold.
An explanation for differences between tox+ strains isolated in the Indian subcontinent and in the United States is not readily apparent. The enigmatic response of tox+ strains associated with infantile diarrhea in the U.S.A. was also seen in the adult rabbit intestinal loop model (11) and in the assay system for intestinal adenyl cyclase (H. Kantor, P. Tao, and S. Gorbach, Abstr. Intersci. Conf. on Antimicrob. Ag. Chemother., p. 103, 1972). Whether the vexing false-negative reactions are the result of an inhibitor or differences in toxin potency remains speculative. The important implication of this work, however, is that before a strain can be labeled tox-it must undergo several skin assays utilizing concentrated cell-free preparations and at least three animals.
Although tox+ E. coli strains from the United States produce unusual PF lesions, this does not pose an insurmountable problem to the use of the PF assay in epidemiological fleld studies. Simple concentration methods can be used to obtain the PF and diarrheagenic factor from broth filtrates of suspected strains. In this manner, it may be possible to determine the role of enterotoxin-producing E. coli in the occurrence of acute diarrhea disease in man. 
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